US drugmaker MSD gets interim relief on diabetes drug patent row

The US pharma major alleged the Indian company was coming out with the diabetes drug with Sitagliptin molecule and its derivatives salt in which it has registered patent right.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news